Results 21 to 30 of about 6,803 (197)

Efficacy and safety of sugammadex in patients undergoing renal transplantation

open access: yesJA Clinical Reports, 2018
Background Sugammadex reverses rocuronium by encapsulating it, creating a stable complex that is mainly excreted by the kidneys. Nonetheless, in view of exposure to sugammadex during renal transplantation, current safety data are insufficient.
Yasumasa Ono   +6 more
doaj   +2 more sources

Sugammadex [PDF]

open access: yesJournal of PeriAnesthesia Nursing, 2016
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing ...
Cada, Dennis J   +2 more
  +8 more sources

Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report- [PDF]

open access: yesKorean Journal of Anesthesiology, 2020
Background In sugammadex-induced anaphylaxis, sugammadex and/or sugammadex-rocuronium complex have possible allergenic epitope. Case We report a case of sugammadex-induced anaphylaxis during general anesthesia in a 60-year-old male undergoing orthopedic ...
Shu Chung Choi   +3 more
doaj   +1 more source

Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats [PDF]

open access: yesRevista Brasileira de Anestesiologia, 2021
Background and objectives: Sugammadex is an alternative pharmacological drug capable of reversing neuromuscular blockades without the limitations that are presented by anticholinesterase drugs.
Ismar Lima Cavalcanti   +6 more
doaj   +3 more sources

Sugammadex reversal of muscle relaxant blockade provided less Post-Anesthesia Care Unit adverse effects than neostigmine/glycopyrrolate

open access: yesJournal of the Formosan Medical Association, 2022
Sugammadex is a direct reversal agent of aminosteroid muscle relaxants, particularly rocuronium, with promptly and completely reverse of deep neuromuscular block (NMB), which allows better surgical conditions. Sugammadex exhibits advantages over indirect
Hsiao-Cheng Chang   +4 more
doaj   +1 more source

Sugammadex

open access: yesCritical Care and Resuscitation, 2013
Sugammadex is the first selective antagonist to reverse neuromuscular blockade induced by rocuronium and vecuronium. The mechanism by which sugammadex works is superior to current neuromuscular block reversal strategies in terms of speed, efficacy and side effects.
Dharshi, Karalapillai   +2 more
  +5 more sources

What we need to know and do on sugammadex usage in pregnant and lactating women and those on hormonal contraceptives [PDF]

open access: yesAnesthesia and Pain Medicine, 2023
Sugammadex is a chemically modified γ-cyclodextrin that is used as a selective reversal agent for steroidal neuromuscular blockade. The use of sugammadex has greatly increased globally; however, little is known about its potential adverse effects in ...
Wangseok Do, Ah-Reum Cho
doaj   +1 more source

Possible immunoglobulin-E-dependent sugammadex-induced anaphylaxis caused by an epitope other than γ-cyclodextrin: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Sugammadex is a synthetic γ-cyclodextrin derivative designed to selectively bind to steroidal neuromuscular blocking agents and reverse their effects.
Tatsuo Horiuchi   +6 more
doaj   +1 more source

Staggering Sugammadex for Reduction of Postoperative Complications: A Randomized Controlled Trial [PDF]

open access: yesZagazig University Medical Journal, 2023
Background: We investigated if staggering sugammadex would reduce postoperative complications(with special regards to cough), compared to single dose of sugammadex or standard neostigmine in patients undergoing thyroidectomy surgery.Methods: A 36 adult ...
Samia El-Wakel   +3 more
doaj   +1 more source

Sugammadex and recurarization in an infant. [PDF]

open access: yes, 2020
Sugammadex is a novel pharmacologic agent, which re- verses neuromuscular blockade via a mechanism that dif- fers completely from acetylcholinesterase inhibitors such as neostigmine.
J. D. Tobias, J. Arends
core   +2 more sources

Home - About - Disclaimer - Privacy